Effects of Very Low Nicotine Content Cigarettes Among Adults Who Smoke Daily in South Korea
NCT07755891 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2026-08-10
Summary
The goal of this clinical trial is to learn how switching to very low nicotine content (VLNC) cigarettes affects smoking behavior and nicotine exposure among adults in South Korea who smoke conventional cigarettes daily. The main questions it aims to answer are:
* Do participants assigned to VLNC cigarettes smoke fewer cigarettes per day during the 7 days before the Week 14 endline visit than those assigned to normal nicotine content (NNC) cigarettes?
* Do participants assigned to VLNC cigarettes have more smoke-free days during the 12-week randomized intervention period than those assigned to NNC cigarettes?
Researchers will compare participants assigned to VLNC cigarettes with those assigned to NNC cigarettes to evaluate differences in smoking behavior, nicotine exposure, dependence, craving, withdrawal symptoms, abstinence-related outcomes, use of other tobacco or nicotine products, product perceptions, policy support, and behavioral patterns assessed using ecological momentary assessment.
Participants will:
* Complete a 1-week baseline period while continuing to smoke their usual-brand cigarettes.
* Be randomly assigned to receive either VLNC or NNC SPECTRUM research cigarettes for 12 weeks.
* Attend scheduled study visits and complete questionnaires, daily surveys, and ecological momentary assessments.
* Provide urine samples for assessment of nicotine exposure and complete other study assessments related to smoking behavior and symptoms.
Up to approximately 350 individuals may be recruited and screened to obtain approximately 300 randomized participants.
Conditions
- Cigarette Smoking
- Nicotine Dependence
Interventions
- OTHER
-
SPECTRUM cigarettes
NRC102 non-menthol SPECTRUM research cigarettes with very low nicotine content (VLNC), containing approximately 0.4 mg nicotine per gram of tobacco. Final product specifications will follow documentation from the National Institute on Drug Abuse (NIDA) and RTI International for the lot used.
- OTHER
-
SPECTRUM cigarettes
NRC600 SPECTRUM research cigarettes with normal nicotine content (NNC), containing approximately 17.36 mg nicotine per gram of tobacco. Final product specifications will follow documentation from the National Institute on Drug Abuse (NIDA) and RTI International for the lot used.
Sponsors & Collaborators
-
Sung-il Cho
lead OTHER
Principal Investigators
-
Sung-il Cho, MD, ScD · Seoul National University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2027-01-31
- Primary Completion
- 2027-05-31
- Completion
- 2027-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation
NCT00141167 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers
NCT02587312 ·Status: COMPLETED ·Phase: NA
-
A Test of Short and Long Term Naturalistic Outcomes of Smokers Who Sample Smokeless Tobacco
NCT01509586 ·Status: COMPLETED ·Phase: NA
-
Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
NCT03272685 ·Status: COMPLETED ·Phase: PHASE3
-
Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine
NCT00777569 ·Status: COMPLETED ·Phase: PHASE2
-
Smoking Cessation Study In Healthy Adolescent Smokers
NCT01312909 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes
NCT03559725 ·Status: COMPLETED ·Phase: PHASE1
-
Low Nicotine Cigarettes Plus Electronic Cigarettes
NCT04058717 ·Status: COMPLETED ·Phase: NA
-
Switching to Very Low Nicotine Content Cigarettes vs Reducing Cigarettes Per Day
NCT03060083 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Varenicline for Smoking Cessation in Heavy Drinking Smokers
NCT00860028 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users
NCT03710590 ·Status: COMPLETED ·Phase: NA
-
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
NCT00580645 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine Reinforcement and Aversion in Young Adult Light Smokers
NCT01495819 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider
NCT01244061 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial of Varenicline for E-cigarette Cessation
NCT07040566 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of an Oral Nicotine Product in Smokeless Tobacco Users
NCT05280769 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of a New Nicotine Replacement Therapy
NCT00764439 ·Status: COMPLETED ·Phase: PHASE2
-
A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking Cessation
NCT00143286 ·Status: COMPLETED ·Phase: PHASE3
-
Are Smokers Switching to Vaping at Lower Risk for Cancer? (Electronic Cigarettes and Cancer Risk)
NCT03750825 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Trial of E-cigarettes in Current Cigarette Smokers
NCT02357173 ·Status: COMPLETED ·Phase: NA
-
Study of Vascular Function Before vs After Smoking an E-cigarette as Compared to a Normal Cigarette
NCT05598125 ·Status: TERMINATED
-
Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing
NCT07161050 ·Status: RECRUITING ·Phase: NA
-
Smoking Research Study
NCT01465880 ·Status: COMPLETED ·Phase: NA
-
Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment
NCT01309685 ·Status: WITHDRAWN ·Phase: PHASE1
-
Switch or Quit R01
NCT06373679 ·Status: RECRUITING ·Phase: NA